<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0213264</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1117</journal-id>
<journal-id journal-id-type="nlm-ta">Biol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Biol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Biological psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-3223</issn>
<issn pub-type="epub">1873-2402</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28256214</article-id>
<article-id pub-id-type="pmc">5796785</article-id>
<article-id pub-id-type="doi">10.1016/j.biopsych.2017.01.009</article-id>
<article-id pub-id-type="manuscript">NIHMS847748</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Opposing effects on Na<sub>V</sub>1.2 function underlie differences between <italic>SCN2A</italic> variants observed in individuals with autism spectrum disorder or infantile seizures</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ben-Shalom</surname>
<given-names>Roy</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Keeshen</surname>
<given-names>Caroline M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Berrios</surname>
<given-names>Kiara N.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>An</surname>
<given-names>Joon Y.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sanders</surname>
<given-names>Stephan J.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="author-notes" rid="FN2">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bender</surname>
<given-names>Kevin J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="author-notes" rid="FN2">6</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Center for Integrative Neuroscience, Kavli Institute for Fundamental Neuroscience, Department of Neurology, University of California, San Francisco, San Francisco, California 94158, USA</aff>
<aff id="A2">
<label>2</label>Computational Research Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA 94720, USA</aff>
<aff id="A3">
<label>3</label>Department of Chemistry, UPR Rio Piedras Campus, Natural Sciences Building, Phase I Room C-134 San Juan, PR 00931</aff>
<aff id="A4">
<label>4</label>Department of Psychiatry, University of California, San Francisco, San Francisco, CA 94158, USA</aff>
<aff id="A5">
<label>5</label>UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94158, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Please address correspondence to: <email>kevin.bender@ucsf.edu</email> (K. J. B.)</corresp>
<fn fn-type="equal" id="FN2">
<label>6</label>
<p>These authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>4</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>27</day>
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>01</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>8</month>
<year>2018</year>
</pub-date>
<volume>82</volume>
<issue>3</issue>
<fpage>224</fpage>
<lpage>232</lpage>
<!--elocation-id from pubmed: 10.1016/j.biopsych.2017.01.009-->
<abstract>
<sec id="S1">
<title>BACKGROUND</title>
<p id="P2">Variants in <italic>SCN2A</italic> that disrupt the encoded neuronal sodium channel Na<sub>V</sub>1.2 are important risk factors for autism spectrum disorder (ASD), developmental delay, and infantile seizures. Variants observed in infantile seizures are predominantly missense, leading to a gain of function and increased neuronal excitability. How variants associated with ASD affect Na<sub>V</sub>1.2 function and neuronal excitability are unclear.</p>
</sec>
<sec id="S2">
<title>METHODS</title>
<p id="P3">We examined the properties of 11 ASD-associated <italic>SCN2A</italic> variants in heterologous expression systems using whole-cell voltage-clamp electrophysiology and immunohistochemistry. Resultant data were incorporated into computational models of developing and mature cortical pyramidal cells that express Na<sub>V</sub>1.2.</p>
</sec>
<sec id="S3">
<title>RESULTS</title>
<p id="P4">In contrast to gain of function variants that contribute to seizure, we found that all ASD-associated variants dampened or eliminated channel function. Incorporating these electrophysiological results into a compartmental model of developing excitatory neurons demonstrated that all ASD variants, regardless of their mechanism of action, resulted in deficits in neuronal excitability. Corresponding analysis of mature neurons predicted minimal change in neuronal excitability.</p>
</sec>
<sec id="S4">
<title>CONCLUSIONS</title>
<p id="P5">This functional characterization thus identifies <italic>SCN2A</italic> mutation and Na<sub>V</sub>1.2 dysfunction as the most frequently observed ASD risk factor detectable by exome sequencing and suggests that associated changes in neuronal excitability, particularly in developing neurons, may contribute to ASD etiology.</p>
</sec>
</abstract>
<kwd-group>
<kwd>autism spectrum disorder</kwd>
<kwd>epilepsy</kwd>
<kwd>seizure</kwd>
<kwd>SCN2A</kwd>
<kwd>Na<sub>V</sub>1.2</kwd>
<kwd>electrophysiology</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>